Long noncoding RNA H19 upregulates vascular endothelial growth factor A to enhance mesenchymal stem cells survival and angiogenic capacity by inhibiting miR-199a-5p

BACKGROUND: Currently, the overall therapeutic efficiency of mesenchymal stem cells (MSCs) transplantation for the treatment of cardiovascular disease is not satisfactory. The low viability and angiogenic capacity of the implanted cells in the local infarct tissues restrict their further application...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Jingying, Wang, Lingyun, Wu, Quanhua, Zheng, Guanghui, Long, Huibao, Wu, Hao, Zhou, Changqing, Guo, Tianzhu, Zhong, Tingting, Wang, Lei, Chen, Xuxiang, Wang, Tong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909270/
https://www.ncbi.nlm.nih.gov/pubmed/29673400
http://dx.doi.org/10.1186/s13287-018-0861-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909270/
https://www.ncbi.nlm.nih.gov/pubmed/29673400
http://dx.doi.org/10.1186/s13287-018-0861-x

Ejemplares similares